Cargando…

Curcumin alleviates persistence of Acinetobacter baumannii against colistin

Persisters are phenotypic variants of normal susceptible bacterial populations that survive prolonged exposure to high doses of antibiotics and are responsible for pertinacious infections and post-treatment relapses. Out of the three antibiotics, Acinetobacter baumannii formed the highest percentage...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Amanjot, Sharma, Prince, Capalash, Neena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056455/
https://www.ncbi.nlm.nih.gov/pubmed/30038318
http://dx.doi.org/10.1038/s41598-018-29291-z
_version_ 1783341338869104640
author Kaur, Amanjot
Sharma, Prince
Capalash, Neena
author_facet Kaur, Amanjot
Sharma, Prince
Capalash, Neena
author_sort Kaur, Amanjot
collection PubMed
description Persisters are phenotypic variants of normal susceptible bacterial populations that survive prolonged exposure to high doses of antibiotics and are responsible for pertinacious infections and post-treatment relapses. Out of the three antibiotics, Acinetobacter baumannii formed the highest percentage of persister cells against rifampicin followed by amikacin and the least against colistin. Colistin-treated cells formed the high levels of reactive oxygen species (ROS) whose quenching with bipyridyl and thiourea led to an increased persister population. Curcumin, a polyphenolic pro-oxidant, significantly decreased persistence against colistin. The quenching of ROS generated by curcumin-colistin combination and the use of resveratrol, an anti-oxidant, with colistin increased the persister population, supporting the significance of ROS in decreased persistence against this combination. The down-regulation of repair genes by this combination in comparison to colistin alone supported the modulation of gene expression in response to ROS and their importance in decreased persistence. Increased membrane permeability by colistin, facilitating the penetration of curcumin into cells and resulting in increased ROS and compromised repair compounded by the decreased efflux of colistin by the inhibition of efflux pumps, may be responsible for enhanced lethality and low persistence. Hence, the curcumin-colistin combination can be another option with anti-persister potential for the control of chronic A. baumannii infections.
format Online
Article
Text
id pubmed-6056455
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-60564552018-07-30 Curcumin alleviates persistence of Acinetobacter baumannii against colistin Kaur, Amanjot Sharma, Prince Capalash, Neena Sci Rep Article Persisters are phenotypic variants of normal susceptible bacterial populations that survive prolonged exposure to high doses of antibiotics and are responsible for pertinacious infections and post-treatment relapses. Out of the three antibiotics, Acinetobacter baumannii formed the highest percentage of persister cells against rifampicin followed by amikacin and the least against colistin. Colistin-treated cells formed the high levels of reactive oxygen species (ROS) whose quenching with bipyridyl and thiourea led to an increased persister population. Curcumin, a polyphenolic pro-oxidant, significantly decreased persistence against colistin. The quenching of ROS generated by curcumin-colistin combination and the use of resveratrol, an anti-oxidant, with colistin increased the persister population, supporting the significance of ROS in decreased persistence against this combination. The down-regulation of repair genes by this combination in comparison to colistin alone supported the modulation of gene expression in response to ROS and their importance in decreased persistence. Increased membrane permeability by colistin, facilitating the penetration of curcumin into cells and resulting in increased ROS and compromised repair compounded by the decreased efflux of colistin by the inhibition of efflux pumps, may be responsible for enhanced lethality and low persistence. Hence, the curcumin-colistin combination can be another option with anti-persister potential for the control of chronic A. baumannii infections. Nature Publishing Group UK 2018-07-23 /pmc/articles/PMC6056455/ /pubmed/30038318 http://dx.doi.org/10.1038/s41598-018-29291-z Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Kaur, Amanjot
Sharma, Prince
Capalash, Neena
Curcumin alleviates persistence of Acinetobacter baumannii against colistin
title Curcumin alleviates persistence of Acinetobacter baumannii against colistin
title_full Curcumin alleviates persistence of Acinetobacter baumannii against colistin
title_fullStr Curcumin alleviates persistence of Acinetobacter baumannii against colistin
title_full_unstemmed Curcumin alleviates persistence of Acinetobacter baumannii against colistin
title_short Curcumin alleviates persistence of Acinetobacter baumannii against colistin
title_sort curcumin alleviates persistence of acinetobacter baumannii against colistin
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056455/
https://www.ncbi.nlm.nih.gov/pubmed/30038318
http://dx.doi.org/10.1038/s41598-018-29291-z
work_keys_str_mv AT kauramanjot curcuminalleviatespersistenceofacinetobacterbaumanniiagainstcolistin
AT sharmaprince curcuminalleviatespersistenceofacinetobacterbaumanniiagainstcolistin
AT capalashneena curcuminalleviatespersistenceofacinetobacterbaumanniiagainstcolistin